BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 28475479)

  • 1. Risk of hemorrhagic transformation after ischemic stroke in patients with antiphospholipid antibody syndrome.
    Mehta T; Hussain M; Sheth K; Ding Y; McCullough LD
    Neurol Res; 2017 Jun; 39(6):477-483. PubMed ID: 28475479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computed Tomography--Verified Leukoaraiosis Is a Risk Factor for Post-thrombolytic Hemorrhage.
    Willer L; Havsteen I; Ovesen C; Christensen AF; Christensen H
    J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1126-30. PubMed ID: 25920756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should we exclude acute stroke patients with previous intracerebral hemorrhage from receiving intravenous thrombolysis?
    Lee SH; Kim BJ; Han MK; Park TH; Lee KB; Lee BC; Yu KH; Oh MS; Cha JK; Kim DH; Nah HW; Lee J; Lee SJ; Ko Y; Kim JG; Park JM; Kang K; Cho YJ; Hong KS; Choi JC; Kim JT; Choi K; Kim DE; Ryu WS; Kim WJ; Shin DI; Yeo M; Lee J; Lee JS; Gorelick PB; Bae HJ
    Int J Stroke; 2016 Oct; 11(7):783-90. PubMed ID: 27312681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does Prior Antiplatelet Treatment Increase the Risk of Hemorrhagic Transformation and Unfavorable Outcome on Day 90 after Intravenous Thrombolysis in Acute Ischemic Stroke Patients?
    Chen S; Lu X; Zhang W; Han Z; Yang W; Huang X; Jin X; Wang Z; Liang H; Qiu W; Cheng J; Shao B
    J Stroke Cerebrovasc Dis; 2016 Jun; 25(6):1366-70. PubMed ID: 26996750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple cerebral microbleeds in hyperacute ischemic stroke: impact on prevalence and severity of early hemorrhagic transformation after thrombolytic treatment.
    Kim HS; Lee DH; Ryu CW; Lee JH; Choi CG; Kim SJ; Suh DC
    AJR Am J Roentgenol; 2006 May; 186(5):1443-9. PubMed ID: 16632743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survey on antiphospholipid syndrome diagnosis and antithrombotic treatment in patients with ischemic stroke, other brain ischemic injury, or arterial thromboembolism in other sites: communication from ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies.
    Cohen H; Werring DJ; Chandratheva A; Mittal P; Devreese KMJ; Isenberg DA;
    J Thromb Haemost; 2023 Oct; 21(10):2963-2976. PubMed ID: 37391096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of in-hospital mortality and the risk of symptomatic intracerebral hemorrhage after thrombolytic therapy with recombinant tissue plasminogen activator in acute ischemic stroke.
    Al-Khaled M; Matthis C; Eggers J
    J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):7-11. PubMed ID: 22578915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke.
    Power A; Epstein D; Cohen D; Bathula R; Devine J; Kar A; Taube D; Duncan N; Ames D
    Cerebrovasc Dis; 2013; 35(1):45-52. PubMed ID: 23428996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombolysis in dementia patients with acute stroke: is it justified?
    Paciaroni M; Pantoni L
    Neurol Sci; 2017 Jan; 38(1):27-31. PubMed ID: 27699498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of thrombolytic therapy for acute ischemic stroke in patients with current malignancy.
    Masrur S; Abdullah AR; Smith EE; Hidalgo R; El-Ghandour A; Rordorf G; Schwamm LH
    J Stroke Cerebrovasc Dis; 2011; 20(2):124-30. PubMed ID: 20598579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of thrombolytic therapy in patients with acute ischemic stroke and the risk of in-hospital mortality: the German Stroke Registers Study Group.
    Heuschmann PU; Berger K; Misselwitz B; Hermanek P; Leffmann C; Adelmann M; Buecker-Nott HJ; Rother J; Neundoerfer B; Kolominsky-Rabas PL; ;
    Stroke; 2003 May; 34(5):1106-13. PubMed ID: 12663875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Older age does not increase risk of hemorrhagic complications after intravenous and/or intra-arterial thrombolysis for acute stroke.
    Pundik S; McWilliams-Dunnigan L; Blackham KL; Kirchner HL; Sundararajan S; Sunshine JL; Tarr RW; Selman WR; Landis DM; Suarez JI
    J Stroke Cerebrovasc Dis; 2008 Sep; 17(5):266-72. PubMed ID: 18755405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiphospholipid antibodies correlate with stroke severity and outcome in patients with antiphospholipid syndrome.
    Rodríguez-Sanz A; Martínez-Sánchez P; Prefasi D; Fuentes B; Pascual-Salcedo D; Blanco-Bañares MJ; Díez-Tejedor E
    Autoimmunity; 2015; 48(5):275-81. PubMed ID: 25434364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of weekend compared with weekday stroke admission on thrombolytic use, in-hospital mortality, discharge disposition, hospital charges, and length of stay in the Nationwide Inpatient Sample Database, 2002 to 2007.
    Hoh BL; Chi YY; Waters MF; Mocco J; Barker FG
    Stroke; 2010 Oct; 41(10):2323-8. PubMed ID: 20724715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombolysis for acute ischemic stroke in patients with cancer: a population study.
    Murthy SB; Karanth S; Shah S; Shastri A; Rao CP; Bershad EM; Suarez JI
    Stroke; 2013 Dec; 44(12):3573-6. PubMed ID: 24065712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antiphospholipid syndrome and stroke].
    Kitagawa Y
    Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two tales: hemorrhagic transformation but not parenchymal hemorrhage after thrombolysis is related to severity and duration of ischemia: MRI study of acute stroke patients treated with intravenous tissue plasminogen activator within 6 hours.
    Thomalla G; Sobesky J; Köhrmann M; Fiebach JB; Fiehler J; Zaro Weber O; Kruetzelmann A; Kucinski T; Rosenkranz M; Röther J; Schellinger PD
    Stroke; 2007 Feb; 38(2):313-8. PubMed ID: 17204683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. National survey of thrombolytic therapy for acute ischemic stroke in Taiwan 2003-2010.
    Hsieh CY; Chen CH; Chen YC; Kao Yang YH
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e620-7. PubMed ID: 24126287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
    J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community-based thrombolytic therapy of acute ischemic stroke in Helsinki.
    Lindsberg PJ; Soinne L; Roine RO; Salonen O; Tatlisumak T; Kallela M; Häppölä O; Tiainen M; Haapaniemi E; Kuisma M; Kaste M
    Stroke; 2003 Jun; 34(6):1443-9. PubMed ID: 12738891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.